AnaptysBio Inc reports results for the quarter ended in March - Earnings Summary

AnaptysBio

11/05/2023 22:55

* AnaptysBio Inc  ANAB.OQ  reported a quarterly adjusted
loss of
$1.58​​ per share for the quarter ended in March. The mean
expectation of six analysts for the quarter was for a loss of
$1.05 per share.
    * Revenue rose 41.6% to $1.37 million from a year ago;
analysts
expected $3.58 million. 
    * AnaptysBio Inc's reported EPS for the quarter was a loss
of
$1.58​.
    * The mean earnings estimate of analysts had fallen by
about 0.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * AnaptysBio Inc shares had fallen by 1.3% this quarter and
lost 30.7% so far this year.
    * The company reported a quarterly loss of $44.26 million.
    * Wall Street's median 12-month price target for AnaptysBio
Inc is
$28.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 5
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
11 at 09:55 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -1.05          -1.58          Missed
 Dec. 31 2022      -0.96          -0.93          Beat
 Sep. 30 2022      -0.72          -1.18          Missed
 Jun. 30 2022      -1.02          -1.15          Missed